CNMD - CONMED Corp

QQQ $ 479.24 $ -0.72 (-0.15 %)

DIA $ 386.46 $ -0.42 (-0.11 %)

SPY $ 542.65 $ 0.33 (0.06 %)

TLT $ 93.70 $ -0.16 (-0.17 %)

GLD $ 215.76 $ 2.76 (1.3 %)

Previous Close

$ 71.11

Open

$ 72.42

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 70.91 - $ 72.42

52 Week Range

$ 60.88 - $ 137.09

Volume

317,894

Average Volume

Market Cap

2.22B

Beta (5Y Monthly)

$ 1.58

PE Ratio (TTM)

$ 27.00

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-25-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	10-26-2023	09-30-2023	10-Q
4	07-27-2023	06-30-2023	10-Q
5	04-27-2023	03-31-2023	10-Q
6	02-21-2023	12-31-2022	10-K
7	10-27-2022	09-30-2022	10-Q
8	07-28-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-22-2022	12-31-2021	10-K
11	10-28-2021	09-30-2021	10-Q
12	07-29-2021	06-30-2021	10-Q
13	04-29-2021	03-31-2021	10-Q
14	02-22-2021	12-31-2020	10-K
15	10-29-2020	09-30-2020	10-Q
16	07-30-2020	06-30-2020	10-Q
17	04-30-2020	03-31-2020	10-Q
18	02-24-2020	12-31-2019	10-K
19	10-31-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	04-26-2019	03-31-2019	10-Q
22	02-25-2019	12-31-2018	10-K
23	11-02-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	04-26-2018	03-31-2018	10-Q
26	02-26-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	07-27-2017	06-30-2017	10-Q
29	04-27-2017	03-31-2017	10-Q
30	02-27-2017	12-31-2016	10-K
31	10-28-2016	09-30-2016	10-Q
32	07-28-2016	06-30-2016	10-Q
33	05-02-2016	03-31-2016	10-Q
34	02-23-2016	12-31-2015	10-K
35	10-23-2015	09-30-2015	10-Q
36	07-27-2015	06-30-2015	10-Q
37	04-24-2015	03-31-2015	10-Q
38	02-23-2015	12-31-2014	10-K
39	10-24-2014	09-30-2014	10-Q
40	07-25-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Conmed, Maintain...
05/06/2024 09:49:36

Needham analyst Mike Matson reiterates Conmed (NYSE:CNMD) with a Buy and maintains $107 price target.

1m-bet-on-skyworks-solutions-check-out-these-3-stocks-insiders-are-buying

$1M Bet On Skyworks Solutions? Check Out T...
05/03/2024 13:02:56

JP Morgan Maintains Overweight on Conmed, ...
04/25/2024 17:38:22

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $115 to $75.

Wells Fargo Maintains Equal-Weight on Conm...
04/25/2024 14:21:25

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $98 to $77.

Piper Sandler Maintains Overweight on Conm...
04/25/2024 12:51:57

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $100 ...

Analyst Scoreboard: 5 Ratings For Conmed
04/25/2024 12:01:45

Needham Maintains Buy on Conmed, Lowers Pr...
04/25/2024 09:55:16

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $129 to $107.

CONMED Corporation Promotes Patrick Beyer ...
04/24/2024 20:58:10

CONMED Corporation (NYSE:CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been ...

CONMED Sees FY24 Adj. EPS $4.25-$4.35 Vs $...
04/24/2024 20:42:17

Conmed Q1 2024 Adj EPS $0.79 Beats $0.74 E...
04/24/2024 20:11:38

Conmed (NYSE:CNMD) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.74 by 6.76 pe...

Cracking The Code: Understanding Analyst R...
02/01/2024 21:00:36

Piper Sandler Maintains Overweight on Conm...
02/01/2024 20:18:48

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $130 ...

JP Morgan Maintains Overweight on Conmed, ...
02/01/2024 14:40:35

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $135 to $115.

these-analysts-revise-their-forecasts-on-conmed-after-q4-results

These Analysts Revise Their Forecasts On C...
02/01/2024 13:42:33

CONMED Corporation (NYSE: CNMD) reported weaker-than-expected fourth-quarter financial results on Wednesday.

Wells Fargo Maintains Equal-Weight on Conm...
02/01/2024 13:27:14

Wells Fargo analyst Durgesh Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $107 to...

AT&T To Rally Around 19%? Here Are 10 Top ...
02/01/2024 12:48:20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Needham Maintains Buy on Conmed, Raises Pr...
02/01/2024 12:22:13

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and raises the price target from $119 to $129.

Recap: Conmed Q4 Earnings
01/31/2024 21:15:20

Conmed Q4 Adj EPS $1.06 Misses $1.11 Estim...
01/31/2024 21:13:35

Conmed (NYSE:CNMD) reported quarterly earnings of $1.06 per share which missed the analyst consensus estimate of $1.11 by 4.5 p...

Earnings Scheduled For January 31, 2024
01/31/2024 11:09:37

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue...

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

CNMDCONMED Corp

NYSE conmed.com

$ 71.12 $ -1.53 (-2.11 %)

Friday, 14-Jun-2024 15:59:54 EDT